GW-842470

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameGW-842470
Drug Alias NameGW-842470XGSK-842470AWD-12-281GW-842470
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPhosphodieterase 4 inhibitors
TargetsPhosphodieterase 4
Therapy Area/IndicationsDermatitis, AtopicRhinitis, AllergicPulmonary Disease, Chronic Obstructive +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNetherlandsGermanyMainland China
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaDiscontinued
Originator CompaniesGlaxosmithkline PlcElbion Nv
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGlaxosmithkline PlcGlaxosmithkline (China) Investment Co Ltd
Active IndicationsN/A
Inactive IndicationsDermatitis, AtopicRhinitis, AllergicPulmonary Disease, Chronic Obstructive +[4] 

Other Information

ATC CodeN/A
Related LinksN/A